← Back to screener

PRECISION BIOSCIENCES INC DTIL

Rank #1412 · Nasdaq · $0.2B market cap
Audited by Deloitte & Touche LLP, no going-concern flag in the latest filing.
Score
48.8
P/E
25.4
P/B
9.66
ROE
38.0%
Op. Margin
-38.1%
Debt Ratio
424%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Average

P/E 25.4x, P/B 9.66x. Ranks in the top 57% of the universe.

Profitability ★★★☆☆
Average

ROE 38.0%. Ranks in the top 48% of the universe.

Safety ★☆☆☆☆
Weak

Debt ratio 424%. Ranks in the top 77% of the universe. Above 200% signals meaningful leverage risk.

Growth ★★★★★
Excellent

Revenue growth of 41.0% year over year. Ranks in the top 9% of the universe.

Growth is the relative strength · Safety is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2019$1.1B$-0.0B$-0.0B$-0.0B-4.5-374
2020$0.0B$-0.1B$-0.1B$0.0B-392.1243
2021$0.0B$-0.1B$-0.1B$0.1B-452.276
2022$0.1B$-0.0B$-0.0B$0.0B-34.1271
2023$0.0B$-0.1B$-0.1B$0.1B-248.3195
2024$0.0B$-0.0B$-0.1B$0.1B-89.8233
2025$0.1B$-0.0B$0.0B$0.0B-38.1424

← See the full screener